Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis

समान संसाधन

• Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(−/−) mice
  द्वारा: Jones, Hannah, और अन्य
  प्रकाशित: (2016)
• BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kit(w-sh) mice
  द्वारा: Hargrove, Laura, और अन्य
  प्रकाशित: (2017)
• Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2(−/−) mice and human cholangiocarcinoma tumorigenesis
  द्वारा: Kennedy, Lindsey, और अन्य
  प्रकाशित: (2018)
• Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2(−/−) Mouse Model of Primary Sclerosing Cholangitis
  द्वारा: Kyritsi, Konstantina, और अन्य
  प्रकाशित: (2020)
• Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2(−/−) mice
  द्वारा: Meadows, Vik, और अन्य
  प्रकाशित: (2019)